Value of contrast-enhanced color Doppler sonography in diagnosing hepatocellular carcinoma with special attention to the 'color-filled pattern'

Journal of Clinical Ultrasound

Volumn 26, Issue 4, 1998, Pages 207-212

  Tanaka, Sachiko ^a   Kitamra, Tsugio ^a   Fujita, Makoto ^a   Yoshioka, Fumi ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Color Doppler ultrasonography; Contrast enhancement; Hepatocellular carcinoma

Indexed keywords

SHU 508;

ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA;

ADULT; AGED; ARTERIES; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0031941799     PISSN: 00912751     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0096(199805)26:4<207::AID-JCU6>3.0.CO;2-H     Document Type: Article

References (12)

1. Merritt CRB: Doppler color flow imaging. J Clin Ultrasound 1987;15:591.
2. Tanaka S, Kitamra T, Fujita M, et al: Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol 1989;154:509.
3. Tanaka S, Kitamra T, Fujita M, et al: Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging. Radiology 1992;182:161.
4. Nino-Murcia M, Ralls PW, Jeffrey RB, et al: Color flow Doppler characterization of focal hepatic lesions. AJR Am J Roentgenol 1992;159:1195.
5. Ohto M, Matsutani S, Mizumoto H, et al: Evaluation of color Doppler using a saccharide based contrast agent, SH/TA-508, on liver tumor - clinical phase 2 study [in Japanese with English abstract]. Japanese Journal of Medical Ultrasonics 1995;22: 461.
6. Takayasu K, Shima Y, Muramatsu Y, et al: Angiography of small hepatocellular carcinomas: analysis of 105 resected tumors. AJR Am J Roentgenol 1986;147:525.
7. Goldberg BB, Hilpert PL, Burns PN, et al: Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent. Radiology 1990;177:713.
8. Rosenkranz K, Zendel W, Langer R, et al: Contrast-enhanced transcranial Doppler US with a new transpulmonary echo contrast agent based on saccharide microparticles. Radiology 1993;187: 439.
9. Goldberg BB, Liu JB, Burns PN, et al: Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med 1993;12: 463.
10. Tanaka S, Kitamra Y, Yoshioka F, et al: Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma. Ultrasound Med Biol 1995;21:157.
11. Hindle AJ, Perkins AC: A perfusion phantom for the evaluation of ultrasound contrast agents. Ultrasound Med Biol 1994;20:309.
12. Miura S, Tashiro H, Kurose I, et al: Intestinal microcirculatory changes during fat absorption and the effect of cholecystokinin inhibitor. Am J Physiol 1992;262:G399.